نمایش مختصر رکورد

dc.contributor.authorBehnam, Behnazen_US
dc.contributor.authorSemnani, Vahiden_US
dc.contributor.authorSaghafi, Nadiaen_US
dc.contributor.authorGhorbani, Raheben_US
dc.contributor.authorDianak Shori, Minaen_US
dc.contributor.authorGhooshchian Choobmasjedi, Samanehen_US
dc.date.accessioned1399-07-09T06:58:58Zfa_IR
dc.date.accessioned2020-09-30T06:58:58Z
dc.date.available1399-07-09T06:58:58Zfa_IR
dc.date.available2020-09-30T06:58:58Z
dc.date.issued2012-08-01en_US
dc.date.issued1391-05-11fa_IR
dc.date.submitted2011-06-29en_US
dc.date.submitted1390-04-08fa_IR
dc.identifier.citationBehnam, Behnaz, Semnani, Vahid, Saghafi, Nadia, Ghorbani, Raheb, Dianak Shori, Mina, Ghooshchian Choobmasjedi, Samaneh. (2012). Gabapentin Effect on Pain Associated with Heroin Withdrawal in Iranian Crack: a Randomized Double-blind Clinical Trial. Iranian Journal of Pharmaceutical Research, 11(3), 979-983. doi: 10.22037/ijpr.2012.1175en_US
dc.identifier.issn1735-0328
dc.identifier.issn1726-6890
dc.identifier.urihttps://dx.doi.org/10.22037/ijpr.2012.1175
dc.identifier.urihttp://ijpr.sbmu.ac.ir/article_1175.html
dc.identifier.urihttps://iranjournals.nlai.ir/handle/123456789/313219
dc.description.abstractGabapentin seems to be a safe and well tolerated medication for treating heroine dependence. This study examined the efficacy of gabapentin for relieving withdrawal-related pain due to heroin use.Sixty men were recruited from an inpatient psychiatric ward of Fatemieh hospital in Semnan and randomized to receive either placebo (n = 30) or gabapentin (1800 mg/day) (n = 30) for 7 days. Subjective Opioid Withdrawal Scale (SOWS) was measured as a self-administered scale for grading body pain at baseline, and on days 1, 2, 3, 4, 6, and 7.Mean of pain score had a significant decrease trend in both gabapentin and placebo groups. Pain severity during the most of detoxification duration was significantly lower in gabapentin group compared with the placebo group.It is suggested that gabapentin may have an effective role in removing heroin withdrawal-related pain.en_US
dc.format.extent450
dc.format.mimetypeapplication/pdf
dc.languageEnglish
dc.language.isoen_US
dc.publisherSchool of Pharmacy, Shahid Beheshti University of Medical Sciencesen_US
dc.relation.ispartofIranian Journal of Pharmaceutical Researchen_US
dc.relation.isversionofhttps://dx.doi.org/10.22037/ijpr.2012.1175
dc.subjectGabapentinen_US
dc.subjectHeroinen_US
dc.subjectIranian cracken_US
dc.subjectPainen_US
dc.subjectPharmacotherapy (Clinical Pharmacy)en_US
dc.subjecttoxicology and Pharmacologyen_US
dc.titleGabapentin Effect on Pain Associated with Heroin Withdrawal in Iranian Crack: a Randomized Double-blind Clinical Trialen_US
dc.typeTexten_US
dc.typeResearch articleen_US
dc.contributor.departmentPsychiatry Group, Semnan University of Medical Sciences, Semnan, Iran.en_US
dc.contributor.departmentPathology Department, Semnan University of Medical Sciences, Semnan, Iran.en_US
dc.contributor.departmentPsychiatry Group, Semnan University of Medical Sciences, Semnan, Iran.en_US
dc.contributor.departmentEpidemiology Group, Semnan University of Medicine, Semnan, Iran.en_US
dc.contributor.departmentSemnan University of Medical Sciences, Semnan, Iran.en_US
dc.contributor.departmentSemnan University of Medical Sciences, Semnan, Iran.en_US
dc.citation.volume11
dc.citation.issue3
dc.citation.spage979
dc.citation.epage983


فایل‌های این مورد

Thumbnail

این مورد در مجموعه‌های زیر وجود دارد:

نمایش مختصر رکورد